INCR
InterCure Ltd.
1W: -4.0%
1M: -14.1%
3M: -40.6%
YTD: -29.1%
1Y: -49.3%
3Y: -59.7%
5Y: -57.1%
$0.73
-0.02 (-2.68%)
After Hours: $0.76 (+0.03, +4.49%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$39.9M
52W Range0.68-1.77
Volume26,301
Avg Volume87,828
Beta0.29
Dividend—
Analyst Ratings
Company Info
CEOAlexander Rabinovich
Employees320
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2019-01-28
Websiteintercure.co
85 Medinat ha-Yehudim Street
Herzliya 4676670
IL
Herzliya 4676670
IL
972 7 7460 5012
About InterCure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Gaenzle Christopher | S-Sale | 4,682 | $54.55 | 2017-09-18 |
| Rush Gregory S | S-Sale | 9,703 | $54.48 | 2017-09-18 |
| Gaenzle Christopher | F-InKind | 4,245 | $54.85 | 2017-09-15 |
| Rush Gregory S | M-Exempt | 71,005 | $10.06 | 2017-09-01 |
| Rush Gregory S | S-Sale | 19,300 | $58.60 | 2017-09-01 |